Related references
Note: Only part of the references are listed.miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2
Virginie Vandewalle et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway
Yu Liang et al.
ONCOGENE (2020)
被撤回的出版物: Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer (Retracted article. See vol. 477, pg. 2687, 2022)
Ying Guo et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Mesenchymal Stem Cell-Secreted Exosome Promotes Chemoresistance in Breast Cancer via Enhancing miR-21-5p-Mediated S100A6 Expression
Tao Luo et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Ovarian carcinoma: pathology review with an emphasis in their molecular characteristics
Leonardo S. Lino-Silva
CHINESE CLINICAL ONCOLOGY (2020)
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Stephanie Lheureux et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo
Lan Liu et al.
ONCOTARGETS AND THERAPY (2019)
Overexpression of miR-21-5p promotes proliferation and invasion of colon adenocarcinoma cells through targeting CHL1
Weihua Yu et al.
MOLECULAR MEDICINE (2018)
Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition
Qiang Li et al.
CELL DEATH & DISEASE (2018)
Effect of exosomal miRNA on cancer biology and clinical applications
Zhenqiang Sun et al.
MOLECULAR CANCER (2018)
Chemoresistance and the Self-Maintaining Tumor Microenvironment
Gulcen Yeldag et al.
CANCERS (2018)
Current Opinions on Chemoresistance: An Overview
Saba Hasan et al.
BIOINFORMATION (2018)
miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN
Xiaomin Yu et al.
ONCOLOGY LETTERS (2017)
Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers
Yali Zhong et al.
ONCOTARGET (2017)
The Glycolytic Switch in Tumors: How Many Players Are Involved?
Li Yu et al.
JOURNAL OF CANCER (2017)
A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer
Ji-Guang Han et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype
Ling Li et al.
CANCER RESEARCH (2016)
PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence
Yaqing Li et al.
ONCOTARGET (2016)
Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation
Yue Jin et al.
ONCOTARGET (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions
Mariano Di Trapani et al.
SCIENTIFIC REPORTS (2016)
Role of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma
Chen-Sung Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells
Ryan Charles Pink et al.
GYNECOLOGIC ONCOLOGY (2015)
Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A
Aldo Germani et al.
CANCER LETTERS (2014)
The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer
John K. Chan et al.
GYNECOLOGIC ONCOLOGY (2014)
Targeting miR-21 Induces Autophagy and Chemosensitivity of Leukemia Cells
Hugo Seca et al.
CURRENT DRUG TARGETS (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Pyruvate dehydrogenase deficiency and epilepsy
Chitra Prasad et al.
BRAIN & DEVELOPMENT (2011)
MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines
Zhi-wei Yu et al.
ORAL ONCOLOGY (2010)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
MicroRNA expression profiles in serous ovarian carcinoma
Eun Ji Nam et al.
CLINICAL CANCER RESEARCH (2008)
Share Paper
